Trade ENTX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Entera Bio Ltd. (ENTX) is trading at US$3.01, up 0.33% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$559.25M. Over the past 52 weeks, ENTX has traded between US$0.91 and US$4.20. On Syfe you can trade ENTX with $0 commission and add it to your watchlist.
| Previous close | US$3.00 |
|---|---|
| Market cap | US$559.25M |
| 52-week range | US$0.91 – US$4.20 |
| Volume | 824.57K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Entera Bio Ltd.
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Year: 2018
Top Midday Gainers
Jul 27, 5:48 PM · MT Newswires
Entera Bio Advances Oral Osteoporosis Drug EB613 With Positive FDA Feedback
Jun 22, 1:03 PM · MT Newswires
Entera Bio Ltd. (ENTX) stock is trading at US$3.01, +0.33% from the previous close of US$3.00.
The market cap for Entera Bio Ltd. (ENTX) stock is approximately US$559.25M.
The 52-week high for Entera Bio Ltd. (ENTX) stock is US$4.20.
The 52-week low for Entera Bio Ltd. (ENTX) stock is US$0.91.
Entera Bio Ltd. (ENTX) does not currently pay a dividend.
Stay on top of ENTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
